Home> Products> velaxfine xr

{ "products": [ { "_id": "666c10e66641561b0446977f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VELAXFINE XR 37.5 ", "description": "VELAXFINE XR 37.5 \nVenlafaxine (37.5mg)\nIntroduction:\n\nVELAXFINE XR 37.5 contains Venlafaxine, an extended-release (XR) formulation designed to treat major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder. With a dosage strength of 37.5mg, VELAXFINE XR 37.5 provides sustained therapeutic effects, significantly improving the quality of life for patients.\nKey Features and Benefits:\n\nAntidepressant Action:\n\nVELAXFINE XR 37.5 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain, which helps improve mood and alleviate symptoms of depression.\nAnxiety Relief:\n\nVenlafaxine is effective in treating various anxiety disorders. It reduces the symptoms of anxiety, including excessive worry, restlessness, and physical symptoms such as palpitations and sweating.\nExtended-Release Formulation:\n\nThe extended-release formulation ensures a steady release of medication over 24 hours, providing consistent symptom relief and reducing the need for multiple daily doses. This improves adherence to the treatment regimen and enhances overall effectiveness.\nImproved Quality of Life:\n\nBy effectively managing symptoms of depression and anxiety, VELAXFINE XR 37.5 helps patients regain control of their lives, enhancing their ability to function socially and professionally.\nWell-Tolerated and Safe:\n\nVELAXFINE XR 37.5 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of depression and anxiety disorders.\nDosage and Administration:\n\nInitial Dosage for Depression and Anxiety:\n\nThe recommended starting dose of VELAXFINE XR 37.5 for adults is 37.5mg once daily, taken in the morning or evening. The dose may be increased gradually based on the patient's response and tolerability.\nMaintenance Dosage:\n\nThe usual maintenance dose ranges from 75mg to 225mg per day. Dosage adjustments should be made in increments of 37.5mg to 75mg at intervals of no less than 4 days.\nAdministration Instructions:\n\nVELAXFINE XR 37.5 capsules should be swallowed whole with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of symptoms, response to treatment, and potential side effects is essential during VELAXFINE XR 37.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/velaxfine-xr-37-5-134393", "price": 58.0, "discountamount": 17.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "SAD", "day", "GAD", "food", "life", "SNRI", "mood", "75mg", "need", "EMAIL", "water", "brain", "lives", "225mg", "37.5mg", "levels", "adults", "option", "control", "ability", "evening", "morning", "response", "patients", "Benefits", "sweating", "24 hours", "adherence", "intervals", "increments", "medication", "depression", "Venlafaxine", "information", "restlessness", "palpitations", "sterispharma", "sterisonline", "Introduction", "Key Features", "CALL/WHATSAPP", "starting dose", "panic disorder", "Initial Dosage", "patient safety", "steady release", "Anxiety Relief", "excessive worry", "dosage strength", "Improved Quality", "physical symptoms", "treatment regimen", "Regular monitoring", "Dosage adjustments", "Maintenance Dosage", "therapeutic efficacy", "Continued Monitoring", "multiple daily doses", "long-term management", "Antidepressant Action", "overall effectiveness", "usual maintenance dose", "potential side effects", "social anxiety disorder", "favorable safety profile", "VELAXFINE XR 37.5 therapy", "various anxiety disorders", "consistent symptom relief", "major depressive disorder", "VELAXFINE XR 37.5 capsules", "gastrointestinal discomfort", "Administration Instructions", "Extended-Release Formulation", "generalized anxiety disorder", "sustained therapeutic effects", "serotonin-norepinephrine reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1910, "imageuri": "https://productimages.withfloats.com/actual/667d14c6ba7e6420d2a4fd30.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d14c6ba7e6420d2a4fd30.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:44:06.065Z", "updatedon": "2024-06-27T07:29:09.447Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/velaxfine-xr-37-5-/1910", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VELAXFINE XR 37.5 ", "category": "NEUROLOGY RANGE", "tags": [ "venlafaxine 37.5 mg", "VELAXFINE XR 37.5", "", "VELAXFINE XR 37.5 side effects", "venlafaxine 37.5mg used for", "venlafaxine urinary side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0e798da3a81d5c69ea26", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "METAPROLATE XR 50", "description": "METAPROLATE XR 50\nMetaprolol XR (50mg)\nMETAPROLATE XR 50 is an extended-release formulation of Metoprolol with a strength of 50mg. Metoprolol belongs to a class of medications known as beta-blockers, which are used to treat various cardiovascular conditions by affecting the heart and circulation. The extended-release (XR) formulation allows for once-daily dosing, providing a consistent therapeutic effect throughout the day.\n\nUses\n\nMETAPROLATE XR 50 is primarily used for:\n\nManaging hypertension (high blood pressure)\nTreating angina pectoris (chest pain)\nImproving survival after a heart attack\nManaging heart failure\nReducing the frequency and severity of migraine headaches. For further information\nEmail : info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp : 7877551268, 7849827488\nBUY NOW\nhttps://www.sterisonline.com/product/metaprolate-xr-50-133328", "price": 56.0, "discountamount": 17.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BUY", "day", "Call", "50mg", "Uses", "class", "Email", "dosing", "WhatsApp", "severity", "survival", "strength", "frequency", "chest pain", "Metoprolol", "medications", "information", "circulation", "sterispharma", "sterisonline", "heart attack", "Metaprolol XR", "beta-blockers", "METAPROLATE XR", "angina pectoris", "XR) formulation", "migraine headaches", "high blood pressure", "Managing hypertension", "Managing heart failure", "extended-release formulation", "consistent therapeutic effect", "various cardiovascular conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1320, "imageuri": "https://productimages.withfloats.com/actual/665f0e7b4328177af1cbfcef.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/665f0e7b4328177af1cbfcef.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:54:17.76Z", "updatedon": "2024-06-04T12:54:17.76Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/metaprolate-xr-50/1320", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPROLATE XR 50", "category": "CARDIOLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0d647b387b17ecbcc6bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "METAPROLATE XR 25 ", "description": "METAPROLATE XR 25 \nMetaprolol XR (25mg)\nMETAPROLATE XR 25 is a medication containing Metoprolol Succinate in an extended-release (XR) formulation with a strength of 25mg. Metoprolol is a beta-blocker commonly prescribed for managing hypertension (high blood pressure), angina (chest pain), and heart failure. The extended-release formulation allows for once-daily dosing, providing sustained therapeutic effects throughout the day.\n\nUses\n\nMETAPROLATE XR 25 is primarily used for:\n\nManaging hypertension (high blood pressure)\nPreventing angina (chest pain)\nImproving survival after a heart attack\nTreating heart failure with reduced ejection fraction\nControlling heart rate in conditions like atrial fibrillation.For further information\nEmail : info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp : 7877551268, 7849827488\nBUY NOW\nFor further information\nEmail : info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp : 7877551268, 7849827488\nBUY NOW\nFor further information\nEmail : info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp : 7877551268, 7849827488\nBUY NOW\nhttps://www.sterisonline.com/product/metaprolate-xr-25-133327", "price": 38.0, "discountamount": 11.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "BUY", "25mg", "Call", "Uses", "Email", "angina", "dosing", "survival", "strength", "WhatsApp", "conditions", "chest pain", "heart rate", "medication", "information", "sterispharma", "sterisonline", "heart attack", "beta-blocker", "heart failure", "Metaprolol XR", "METAPROLATE XR", "atrial fibrillation", "high blood pressure", "Metoprolol Succinate", "Managing hypertension", "reduced ejection fraction", "extended-release formulation", "sustained therapeutic effects", "extended-release (XR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1319, "imageuri": "https://productimages.withfloats.com/actual/665f0d664f159c14e15fe3da.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f0d664f159c14e15fe3da.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:49:40.462Z", "updatedon": "2024-06-04T12:49:40.462Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/metaprolate-xr-25-/1319", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPROLATE XR 25 ", "category": "CARDIOLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0a5b87f0960e14a296c7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "METAPROLATE XR 100", "description": "METAPROLATE XR 100\nMetaprolol PR (100mg)\nMETAPROLATE XR 100 is a pharmaceutical product containing Metoprolol as its active ingredient in a prolonged-release (PR) formulation, with a strength of 100mg. Metoprolol is a beta-blocker widely used to manage hypertension (high blood pressure), angina pectoris (chest pain), and heart rhythm disorders. The prolonged-release formulation ensures a steady release of the medication over time, providing extended therapeutic effects and improving patient compliance.\n\nUses\n\nMETAPROLATE XR 100 is primarily used for:\n\nManaging hypertension (high blood pressure)\nPreventing and treating angina pectoris (chest pain)\nTreating heart rhythm disorders (arrhythmias)\nReducing the risk of heart attacks in patients with a history of cardiovascular events\nImproving survival after a heart attack. For further information\nEmail : info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp : 7877551268, 7849827488\nBUY NOW\nhttps://www.sterisonline.com/product/metaprolate-xr-100-133325", "price": 82.0, "discountamount": 25.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BUY", "risk", "time", "Call", "Uses", "100mg", "Email", "history", "survival", "patients", "WhatsApp", "strength", "chest pain", "medication", "Metoprolol", "arrhythmias", "information", "sterispharma", "beta-blocker", "sterisonline", "heart attacks", "Metaprolol PR", "METAPROLATE XR", "steady release", "angina pectoris", "active ingredient", "patient compliance", "high blood pressure", "cardiovascular events", "Managing hypertension", "pharmaceutical product", "heart rhythm disorders", "extended therapeutic effects", "prolonged-release formulation", "prolonged-release (PR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1316, "imageuri": "https://productimages.withfloats.com/actual/665f0a5e7b1fc3f9dd48926a.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/665f0a5e7b1fc3f9dd48926a.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:36:43.833Z", "updatedon": "2024-06-04T12:36:43.833Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/metaprolate-xr-100/1316", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPROLATE XR 100", "category": "CARDIOLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f09b174d94b15a06c3759", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "METAPROLATE XR 12.5 ", "description": "METAPROLATE XR 12.5 \nMetaprolol PR (12.5mg)\nMETAPROLATE XR 12.5 is a medication containing Metoprolol in a prolonged-release (PR) formulation with a strength of 12.5mg. Metoprolol is a beta-blocker, a class of drugs commonly used to manage various cardiovascular conditions. This medication is designed to release Metoprolol gradually over time, ensuring a steady and prolonged therapeutic effect, which helps in maintaining stable blood levels of the drug.\n\nUses\n\nMETAPROLATE XR 12.5 is primarily used for:\n\nTreating high blood pressure (hypertension)\nManaging angina pectoris (chest pain)\nImproving survival after a heart attack\nTreating heart failure\nManaging certain types of irregular heartbeats (arrhythmias)\nPreventing migraines.For further information\nEmail : info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp : 7877551268, 7849827488\nBUY NOW\nhttps://www.sterisonline.com/product/metaprolate-xr-12-5-133326", "price": 36.0, "discountamount": 11.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BUY", "Uses", "time", "Call", "drugs", "Email", "class", "types", "12.5mg", "steady", "strength", "survival", "WhatsApp", "migraines", "Metoprolol", "chest pain", "medication", "arrhythmias", "information", "hypertension", "sterispharma", "beta-blocker", "sterisonline", "heart attack", "heart failure", "Metaprolol PR", "METAPROLATE XR", "angina pectoris", "prolonged-release", "high blood pressure", "stable blood levels", "irregular heartbeats", "prolonged therapeutic effect", "various cardiovascular conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1314, "imageuri": "https://productimages.withfloats.com/actual/665f09b3c06ee12d88cb3c2e.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f09b3c06ee12d88cb3c2e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:33:53.155Z", "updatedon": "2024-06-04T12:33:53.155Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metaprolate-xr-12-5-/1314", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPROLATE XR 12.5 ", "category": "CARDIOLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-10-02T11:20:20.402Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d518ce6b4e65282a1dc798", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Formoterol Fumarate Dihydrate Ip 6 mcg & Budesonide IP 400 mcg", "description": "BUDESHINE F 400 CAP - This is a combination inhalation therapy used in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD).\n\n \nMechanism of Action:\n\nFormoterol Fumarate: A long-acting β2-adrenergic agonist (LABA) that relaxes airway smooth muscles, providing rapid and sustained bronchodilation.\n\nBudesonide: An inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and mucus production.\n\nTogether, they offer dual action—quick relief of bronchospasm and long-term control of airway inflammation.\n\n \n\nIndications:\n\nAsthma (for patients not controlled adequately with inhaled corticosteroids alone).\n\nChronic Obstructive Pulmonary Disease (COPD) with reversible airway obstruction.\n\nPrevention of asthma attacks and reduction of COPD exacerbations.\n\n \n\nKey Benefits:\n\nProvides fast and sustained relief from breathing difficulty.\n\nControls both inflammation and bronchospasm.\n\nReduces the frequency and severity of asthma/COPD flare-ups.\n\nImproves overall lung function and quality of life.\n\n \nDosage and Administration:\n\nAdministered via inhalation as directed by a physician.\n\nDose depends on the severity of disease and patient response.\n\nRegular use is required for effective control—not for acute asthma attacks.\n(Exact dosing schedule to be prescribed by the doctor.)", "price": 238.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2181, "imageuri": "https://productimages.withfloats.com/actual/68d518d1c1505f341d018bb1.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d518d1c1505f341d018bb1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:26:22.554Z", "updatedon": "2025-09-25T10:26:22.554Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/formoterol-fumarate-dihydrate-ip-6-mcg-budesonide-ip-400-mcg/2181", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUDESHINE F 400 CAP", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d2786bf4017fefeee0b981", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ketorolac tromethamine dispersible tablets 10 mg", "description": "KEYPROFEN DT is a fast-acting nonsteroidal anti-inflammatory drug (NSAID) used to relieve moderate pain and inflammation. Its dispersible tablet form ensures quick dissolution and faster pain relief, making it convenient for oral administration. Ideal for managing post-operative pain, musculoskeletal discomfort, and other short-term pain conditions.", "price": 166.0, "discountamount": 49.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2180, "imageuri": "https://productimages.withfloats.com/actual/68d2786fd0799a6bd13134e7.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d2786fd0799a6bd13134e7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-23T10:37:31.507Z", "updatedon": "2025-09-23T10:37:31.507Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ketorolac-tromethamine-dispersible-tablets-10-mg/2180", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "KEYPROFEN DT", "category": "GENERAL RANGE", "tags": [ "KEYPROFEN DT", "ketorolac tromethamine dispersible tablets 10 mg uses in hindi", "ketorolac tromethamine dispersible tablets 10 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }